← Leaderboards
Rene Lynn Utianski
Mayo Clinic Rochester
$1,193,160
Attributed
$2,386,319
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2023–25$2M$1.5M$1M$500K$0
'23
'24
'25
Funding mix
By agency
NIH$2,386,319 · 2
By mechanism
R01$1,945,219 · 1
R21$441,100 · 1
Top collaborators
- Keith A Josephs3 shared
- Gabriela Meade1 shared
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Jennifer Louise Whitwell$16,907,629
- Keith A Josephs$19,660,217
- Adam L Boxer$75,127,044
- William W Seeley$26,843,727
- Howard J Rosen$46,265,858
Others in their field
Other Rising Stars on “Alzheimer&Apos”
- Kjetil Bjornevik · Harvard University D/B/A Harvard School Of Public Health$3,280,861
- Yanling Wang · Rush University Medical Center$2,986,919
- William G Mantyh · University Of Minnesota$2,961,521
- Allison Mercedes Caban-Holt · University Of Miami School Of Medicine$2,611,182
- Brian Stephen Appleby · Cleveland Clinic Lerner Com-Cwru$2,482,260
- Noah Ray Johnson · University Of Colorado Denver$2,282,487
Research focus
Alzheimer&AposAphasiaDisease ProgressionS Disease Related DementiaCostCommunicationNeurologicNeuroimagingPhenotypeS DiseaseSpeechSyndromeReportingProspectiveDiagnosisDifferential DiagnosisEvolutionLanguageBrain ScanBrain InjuriesApraxiaBrainBiologicalCorticobasal Degeneration
Grant awards (4)
The neurobiology of two distinct subtypes of neurodegenerative apraxia of speech: phenotypes of Alzheimer disease related 4-repeat tauopathies$643,385
R01 · FY2025 · DC
Digital detection of handwriting impairments in patients with atypical Alzheimerâs disease and frontotemporal dementia$441,100
R21 · FY2025 · AG
The neurobiology of two distinct subtypes of neurodegenerative apraxia of speech: phenotypes of Alzheimer disease related 4-repeat tauopathies$650,000
R01 · FY2024 · DC
The neurobiology of two distinct subtypes of neurodegenerative apraxia of speech: phenotypes of Alzheimer disease related 4-repeat tauopathies$651,834
R01 · FY2023 · DC